Researchers at Stanford University are investigating solid tumor microenvironment response to focused ultrasound ablation combined with cancer immunotherapies.
The combination treatment induced distinct responses in each of the two models.
The Foundation- and NIH-funded preclinical study was conducted in models of breast and pancreatic cancer.
Dr. Lewis-Hall has spent more than 40 years in healthcare as a clinician, researcher, and leader in the biopharmaceutical and life sciences industries.
She has been involved with the Foundation since 2021 as a member of the Council.
In this blog post, Mark Carol, MD, a senior consultant at the Foundation, addresses a common misconception about the facility costs of focused ultrasound treatments.
Learn why most focused ultrasound procedures are a more profitable use of MRI machines for hospitals than diagnostic studies.
“I am passionate about advancing the development, delivery, and deployment of transformational technology with the potential to save lives. I believe focused ultrasound to be such a technology.”